Preconception maternal nutrition: A multi-site randomized controlled trial

K. M. Hambidge, Nancy F. Krebs, Jamie E. Westcott, Ana Garces, Shivaprasad S. Goudar, Balachandra S. Kodkany, Omrana Pasha, Antoinette Tshefu, Carl L. Bose, Lester Figueroa, Robert L. Goldenberg, Richard J. Derman, Jacob E. Friedman, Daniel N. Frank, Elizabeth M. McClure, Kristen Stolka, Abhik Das, Marion Koso-Thomas, Shelly Sundberg

Research output: Contribution to journalArticle

Abstract

Background: Research directed to optimizing maternal nutrition commencing prior to conception remains very limited, despite suggestive evidence of its importance in addition to ensuring an optimal nutrition environment in the periconceptional period and throughout the first trimester of pregnancy.Methods/Study design: This is an individually randomized controlled trial of the impact on birth length (primary outcome) of the time at which a maternal nutrition intervention is commenced: Arm 1: ≥ 3 mo preconception vs. Arm 2: 12-14 wk gestation vs. Arm 3: none.192 (derived from 480) randomized mothers and living offspring in each arm in each of four research sites (Guatemala, India, Pakistan, Democratic Republic of the Congo). The intervention is a daily 20 g lipid-based (118 kcal) multi-micronutient (MMN) supplement. Women randomized to receive this intervention with body mass index (BMI) <20 or whose gestational weight gain is low will receive an additional 300 kcal/d as a balanced energy-protein supplement. Researchers will visit homes biweekly to deliver intervention and monitor compliance, pregnancy status and morbidity; ensure prenatal and delivery care; and promote breast feeding. The primary outcome is birth length. Secondary outcomes include: fetal length at 12 and 34 wk; incidence of low birth weight (LBW); neonatal/infant anthropometry 0-6 mo of age infectious disease morbidity; maternal, fetal, newborn, and infant epigenetics; maternal and infant nutritional status; maternal and infant microbiome; gut inflammatory biomarkers and bioactive and nutritive compounds in breast milk. The primary analysis will compare birth Length-for-Age Z-score (LAZ) among trial arms (independently for each site, estimated effect size: 0.35). Additional statistical analyses will examine the secondary outcomes and a pooled analysis of data from all sites.Discussion: Positive results of this trial will support a paradigm shift in attention to nutrition of all females of child-bearing age.Trial registration: ClinicalTrials.gov NCT01883193.

Original languageEnglish (US)
Article number111
JournalBMC pregnancy and childbirth
Volume14
Issue number1
DOIs
StatePublished - Mar 20 2014

Keywords

  • Birth length
  • Epigenetics
  • Maternal
  • Microbiome
  • Nutrition
  • Preconception

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Preconception maternal nutrition: A multi-site randomized controlled trial'. Together they form a unique fingerprint.

  • Cite this

    Hambidge, K. M., Krebs, N. F., Westcott, J. E., Garces, A., Goudar, S. S., Kodkany, B. S., Pasha, O., Tshefu, A., Bose, C. L., Figueroa, L., Goldenberg, R. L., Derman, R. J., Friedman, J. E., Frank, D. N., McClure, E. M., Stolka, K., Das, A., Koso-Thomas, M., & Sundberg, S. (2014). Preconception maternal nutrition: A multi-site randomized controlled trial. BMC pregnancy and childbirth, 14(1), [111]. https://doi.org/10.1186/1471-2393-14-111